The 1.02x price-to-sales and 9.55x P/FCF look undemanding against Sonos at 165.84x EV/EBITDA, but part of that discount appears structural: an outsourced model with capex near 1.6% of revenue generates cash without owning much productive asset, so cash-flow multiples flatter comparison with factory-heavy peers. The inversion of forward P/E (28.12x) above trailing P/E (21.27x) while forward EV/EBITDA (12.07x) sits marginally below the trailing 12.28x suggests the market is underwriting roughly stable EBITDA but weaker bottom-line conversion, a divergence that investors should test against interest expense, tax items and non-recurring charges rather than read as a simple growth premium.

Because operating margin has swung from -32.8% in 2026Q1 to +17.9% in 2025Q4, the most honest read of current earning power appears to be gross margin less a normalized fixed-cost load, rather than any single quarter's reported operating or net result. The 10.5% FCF margin in 2026Q2 against a -13.0% net margin, consistent with the previously noted gap between cumulative operating cash flow and cumulative net income, implies reported income understates cash generation but may also overstate how durable profitability is once working-capital reversals unwind.

Asset turnover of 0.18 in 2026Q1 and 0.27 in 2026Q2, against 0.43 in 2025Q4, reflects both the seasonal revenue trough and an asset base materially inflated by goodwill, so the ratio likely understates how intensively the operating assets are actually used. With payables held at 63-64 days while inventory days run 159-183, suppliers appear to fund only a minority of the carry, which leaves the conversion cycle dependent on internal cash generation and revolver availability during the pre-holiday build, investors should monitor whether the 150-day 2026Q2 position normalizes toward the 95-111 days seen in prior-year second halves.

Negative coverage is not unprecedented in this series, with -0.55x in 2025Q2 and -1.22x in 2024Q2, so the current reading may reflect seasonality rather than a fresh deterioration; the more telling deviation is that 1.00x D/E is well above the 0.66 recorded in each prior second quarter, hinting at slower post-holiday de-levering. Coverage recovered to 10.40x in 2025Q4 and 7.74x in 2024Q4, so the burden appears serviceable if peak-season earnings repeat at similar scale, but D/EBITDA data is unavailable for the most recent quarters, leaving the debt-to-equity path as the cleaner gauge of refinancing pressure.